Back to STATE STREET CORP STATE STREET CORP

LYELLYEL
5 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in LYELL IMMUNOPHARMA INC

STATE STREET CORP holds 185,322 shares of LYEL (LYELL IMMUNOPHARMA INC), worth $2.6M as of 2026-Q2. The position was increased (+155.5% shares). LYEL represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$2.6M

Current Shares

185,322

Total Value Change

+$2.3M

Total Shares Change

+151,475

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
185,322
+155.5%
$2.6M0.0%$14.05
42
2026-Q1
Increased
72,522
+40.9%
$1.5M0.0%$23.33
34
2025-Q4
Increased
51,472
+52.5%
$1.6M0.0%$31.59
36
2025-Q3
Decreased
33,752
-0.3%
$548,1320.0%$14.97
0
2025-Q2
New
33,847
-
$299,2070.0%$8.94
36

Other major holders of LYEL: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used